| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.53 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |